Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Nov;27(11):919-927.
doi: 10.1007/s10157-023-02385-3. Epub 2023 Jul 27.

Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study

Tomoya Shukuri  1 , Kentaro Nakai  1 , Shigeru Tanaka  2 , Shunsuke Yamada  2 , Masanori Tokumoto  1 , Kazuhiko Tsuruya  3 , Toshiaki Nakano  4 , Takanari Kitazono  2
Affiliations
Observational Study

Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study

Tomoya Shukuri et al. Clin Exp Nephrol. 2023 Nov.

Abstract

Background: Angiotensin II receptor blockers (ARBs) reportedly reduce the risk of developing bone fractures; however, this association remains unclear among patients with chronic kidney disease (CKD).

Methods: This was a cross-sectional study of 3380 CKD patients enrolled in the Fukuoka Kidney disease Registry Study, a multicenter prospective observational cohort study of non-dialysis-dependent CKD patients. The patients were divided into two groups, those taking ARBs and those who were not. Logistic regression models were used to examine the association between ARBs and bone fracture.

Results: Approximately 67.0% of the participants were on ARBs, and 6.3% had a history of bone fracture. The history of bone fracture was significantly lower in patients with prescribed ARB and remained significant even after multivariable adjustment (odds ratio, 0.68; 95% confidence interval, 0.51-0.93). Other antihypertensive drugs, such as thiazide diuretics, which were reportedly helpful in preventing fractures, did not alter the bone fracture history and did not change among ARB users and non-users.

Conclusions: The present study showed that administering ARB was significantly associated with a lower frequency of bone fracture history.

Keywords: Bone fracture; Chronic kidney disease; Fukuoka Kidney disease Registry Study; angiotensin II receptor blockers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS ONE. 2016. https://doi.org/10.1371/journal.pone.0158765 . - DOI - PubMed - PMC
    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47. - PubMed
    1. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30. - PubMed
    1. Kim SM, Long J, Montez-Rath M, Leonard M, Chertow GM. Hip fracture in patients with non-dialysis-requiring chronic kidney disease. J Bone Miner Res. 2016;31:1803–9. - PubMed
    1. Vilaca T, Salam S, Schini M, Harnan S, Sutton A, Poku E, et al. Risks of hip and nonvertebral fractures in patients with CKD G3a–G5D: a systematic review and meta-analysis. Am J Kidney Dis. 2020;76:521–32. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources